Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,574,157
-
Share change
-
-845,807
-
Total reported value
-
$268,173,148
-
Put/Call ratio
-
118%
-
Price per share
-
$13.70
-
Number of holders
-
79
-
Value change
-
-$11,794,874
-
Number of buys
-
51
-
Number of sells
-
27
Institutional Holders of AKCEA THERAPEUTICS INC - COM (AKCA) as of Q2 2020
As of 30 Jun 2020,
AKCEA THERAPEUTICS INC - COM (AKCA) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,574,157 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and Point72 Asset Management, L.P..
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.